Increased Mortality in Antecedent Combined Renin-Angiotensin System Inhibitors and Antiplatelets Compared With Antiplatelets Alone in Hospitalized Patients With COVID-19.

Lee, Yi; Jehangir, Qasim; Kaur, Jasmeet; Abdou, Asrar; Ibrahim, Mohammed; Mandeel, Mohamed N; Dixit, Priyadarshini; Lal, Amar; Kulkarni, Mayuri; Mohammed, Yaqub N; Pulipati, Priyanjali; Duong, Jacky

Lee, Yi; Jehangir, Qasim; Kaur, Jasmeet; Abdou, Asrar; Ibrahim, Mohammed; Mandeel, Mohamed N; Dixit, Priyadarshini; Lal, Amar; Kulkarni, Mayuri; Mohammed, Yaqub N; Pulipati, Priyanjali; Duong, Jacky.

Lee Y; Internal Medicine Department, St. Joseph Mercy Oakland Hospital, Pontiac, MI.

Am J Ther ; 28(5): e587-e590, 2021 06 25.

Article in English | MEDLINE | ID: covidwho-1398187

Subject(s)

COVID-19; Hypertension; Angiotensin Receptor Antagonists/pharmacology; Angiotensin Receptor Antagonists/therapeutic use; Antihypertensive Agents/therapeutic use; Humans; Hypertension/drug therapy; Renin-Angiotensin System; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypertension Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google